Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Facts Previous | All Articles This Week | Next
This article originally posted 15 February, 2012 and appeared in  Medication, Issue 613

Endocrinologists Would Prescribe Bydureon for 20 Percent of Patients

Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed. Decision Resources announced the results of a survey of US endocrinologists who said they would prescribe Bydureon to 20% of their patients taking into consideration the reimbursement hurdles and competition that the drug could face.
Advertisement

Related Articles

FDA Approves Two Generics of Clopidogrel (Plavix) FDA Approves Labeling Changes for All Statins Two New Weight Loss Drugs Approved by FDA Advisory Committee
Advertisement

 

Bookmark and Share | Print | Category | Home

This article originally posted 15 February, 2012 and appeared in  Medication, Issue 613

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD

Announcement:
 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control